Analyze Diet
PloS one2021; 16(7); e0253840; doi: 10.1371/journal.pone.0253840

Effect of sugar metabolite methylglyoxal on equine lamellar explants: An ex vivo model of laminitis.

Abstract: Laminitis is one of the most devastating diseases in equine medicine, and although several etiopathogenetic mechanisms have been proposed, few clear answers have been identified to date. Several lines of evidence point towards its underlying pathology as being metabolism-related. In the carbonyl stress pathway, sugars are converted to methylglyoxal (MG)-a highly reactive α-oxoaldehyde, mainly derived during glycolysis in eukaryotic cells from the triose phosphates: D-glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. One common hypothesis is that MG could be synthesized during the digestive process in horses, and excessive levels absorbed into peripheral blood could be delivered to the foot and lead to alterations in the hoof lamellar structure. In the present study, employing an ex vivo experimental design, different concentrations of MG were applied to hoof explants (HE), which were then incubated and maintained in a specific medium for 24 and 48 h. Macroscopic and histological analyses and a separation force test were performed at 24 and 48 h post-MG application. Gene expression levels of matrix metalloproteinase (MMP)-2 and -14 and tissue inhibitor of metalloproteinase (TIMP)-2 were also measured at each time point for all experimental conditions. High concentrations of MG induced macroscopic and histological changes mimicking laminitis. The separation force test revealed that hoof tissue samples incubated for 24 h in a high concentration of MG, or with lower doses but for a longer period (48 h), demonstrated significant weaknesses, and samples were easily separated. All results support that high levels of MG could induce irreversible damage in HEs, mimicking laminitis in an ex vivo model.
Publication Date: 2021-07-27 PubMed ID: 34314429PubMed Central: PMC8315528DOI: 10.1371/journal.pone.0253840Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the effect of sugar metabolite methylglyoxal (MG) on equine lamellar explants, suggesting a potential link between high MG levels and the development of laminitis, a severe horse disease, using an ex-vivo model.

Background

  • The study looks into laminitis, one of the most damaging diseases in equine medicine. Despite extensive research, clear answers and solutions have been hard to find.
  • The researchers paid attention to evidence that implied that this condition could be metabolism-related. They focused on a biological process known as carbonyl stress pathway, where sugars are converted to methylglyoxal, a highly reactive α-oxoaldehyde.
  • They explored the hypothesis that MG could be produced during a horse’s digestion process and, if absorbed into the blood in excessive levels, it may cause alterations in the hoof lamellar structure, potentially leading to laminitis.

Methodology

  • Using an ex vivo experimental design, the researchers applied different concentrations of MG to hoof explants (HE) and then incubated them in a specific medium for 24 and 48 hours.
  • The effects were studied using macroscopy, histology, a separation force test and gene expression levels of matrix metalloproteinase (MMP)-2 and -14, and tissue inhibitor of metalloproteinase (TIMP)-2 at the 24h and 48h intervals.

Findings

  • High MG concentrations induced macroscopic and histological changes that resembled laminitis.
  • The force testing showed that hoof tissue samples incubated in a high concentration of MG for 24 hours, or in lower concentrations for 48 hours, were significantly weaker and could be easily separated, suggesting tissue damage.
  • Overall, the results supported the hypothesis that high concentrations of MG could impose irreversible damage on hoof explants, manifesting similar conditions to laminitis in an ex vivo setting.

Cite This Article

APA
Vercelli C, Tursi M, Miretti S, Giusto G, Gandini M, Re G, Valle E. (2021). Effect of sugar metabolite methylglyoxal on equine lamellar explants: An ex vivo model of laminitis. PLoS One, 16(7), e0253840. https://doi.org/10.1371/journal.pone.0253840

Publication

ISSN: 1932-6203
NlmUniqueID: 101285081
Country: United States
Language: English
Volume: 16
Issue: 7
Pages: e0253840
PII: e0253840

Researcher Affiliations

Vercelli, Cristina
  • Department of Veterinary Science, University of Turin, Grugliasco (TO), Italy.
Tursi, Massimiliano
  • Department of Veterinary Science, University of Turin, Grugliasco (TO), Italy.
Miretti, Silvia
  • Department of Veterinary Science, University of Turin, Grugliasco (TO), Italy.
Giusto, Gessica
  • Department of Veterinary Science, University of Turin, Grugliasco (TO), Italy.
Gandini, Marco
  • Department of Veterinary Science, University of Turin, Grugliasco (TO), Italy.
Re, Giovanni
  • Department of Veterinary Science, University of Turin, Grugliasco (TO), Italy.
Valle, Emanuela
  • Department of Veterinary Science, University of Turin, Grugliasco (TO), Italy.

MeSH Terms

  • Animals
  • Gene Expression / drug effects
  • Hoof and Claw / cytology
  • Hoof and Claw / metabolism
  • Hoof and Claw / pathology
  • Horses
  • Male
  • Matrix Metalloproteinase 14 / genetics
  • Matrix Metalloproteinase 14 / metabolism
  • Matrix Metalloproteinase 2 / genetics
  • Matrix Metalloproteinase 2 / metabolism
  • Models, Biological
  • Pyruvaldehyde / analysis
  • Pyruvaldehyde / metabolism
  • Pyruvaldehyde / pharmacology
  • Sugars / metabolism
  • Tissue Inhibitor of Metalloproteinase-2 / genetics
  • Tissue Inhibitor of Metalloproteinase-2 / metabolism

Conflict of Interest Statement

The authors have declared that no competing interests exist.

References

This article includes 36 references
  1. Steelman SM, Johnson D, Wagner B, Stokes A, Chowdhary BP. Cellular and humoral immunity in chronic equine laminitis.. Vet Immunol Immunopathol 2013 Jun 15;153(3-4):217-26.
    doi: 10.1016/j.vetimm.2013.03.001pubmed: 23521925google scholar: lookup
  2. . Lameness & Laminitis in U.S. Horses. United States Department of Agriculture Report #N318.0400. 2000; 1–40.
  3. Medina-Torres CE, Mason SL, Floyd RV, Harris PA, Mobasheri A. Hypoxia and a hypoxia mimetic up-regulate matrix metalloproteinase 2 and 9 in equine laminar keratinocytes.. Vet J 2011 Nov;190(2):e54-e59.
    doi: 10.1016/j.tvjl.2011.02.026pubmed: 21459025google scholar: lookup
  4. Katz LM, Bailey SR. A review of recent advances and current hypotheses on the pathogenesis of acute laminitis.. Equine Vet J 2012 Nov;44(6):752-61.
  5. Wells-Smith L. Laminitis in the 21st century.. Vet Rec 2015 Jan 17;176(3):70-1.
    doi: 10.1136/vr.h53pubmed: 25598466google scholar: lookup
  6. Ziegler D, Schleicher E, Strom A, Knebel B, Fleming T, Nawroth P, Häring HU, Papanas N, Szendrödi J, Müssig K, Al-Hasani H, Roden M. Association of transketolase polymorphisms with measures of polyneuropathy in patients with recently diagnosed diabetes.. Diabetes Metab Res Rev 2017 May;33(4).
    pubmed: 27103086doi: 10.1002/dmrr.2811google scholar: lookup
  7. Milinovich GJ, Burrell PC, Pollitt CC, Klieve AV, Blackall LL, Ouwerkerk D, Woodland E, Trott DJ. Microbial ecology of the equine hindgut during oligofructose-induced laminitis.. ISME J 2008 Nov;2(11):1089-100.
    doi: 10.1038/ismej.2008.67pubmed: 18580970google scholar: lookup
  8. Pollitt CC, Visser MB. Carbohydrate alimentary overload laminitis.. Vet Clin North Am Equine Pract 2010 Apr;26(1):65-78.
    pubmed: 20381736doi: 10.1016/j.cveq.2010.01.006google scholar: lookup
  9. Hoffman RM. Carbohydrate metabolism and metabolic disorders in horses. R Bras Zootec 2009 Jul;38(spe):270–6.
  10. de Laat MA, Kyaw-Tanner MT, Sillence MN, McGowan CM, Pollitt CC. Advanced glycation endproducts in horses with insulin-induced laminitis.. Vet Immunol Immunopathol 2012 Jan 15;145(1-2):395-401.
    doi: 10.1016/j.vetimm.2011.12.016pubmed: 22240145google scholar: lookup
  11. Valle E, Storace D, Sanguineti R, Carter R, Odetti P, Geor R, Bergero D. Association of the glycoxidative stress marker pentosidine with equine laminitis.. Vet J 2013 Jun;196(3):445-50.
    doi: 10.1016/j.tvjl.2012.10.030pubmed: 23206662google scholar: lookup
  12. Valle E, Prola L, Vergnano D, Borghi R, Monacelli F, Traverso N, Bruni N, Bovero A, Schiavone A, Nery J, Bergero D, Odetti P. Investigation of hallmarks of carbonyl stress and formation of end products in feline chronic kidney disease as markers of uraemic toxins.. J Feline Med Surg 2019 Jun;21(6):465-474.
    doi: 10.1177/1098612X18783858pubmed: 30015556google scholar: lookup
  13. Teodorowicz M, Hendriks WH, Wichers HJ, Savelkoul HFJ. Immunomodulation by Processed Animal Feed: The Role of Maillard Reaction Products and Advanced Glycation End-Products (AGEs).. Front Immunol 2018;9:2088.
    doi: 10.3389/fimmu.2018.02088pmc: PMC6146089pubmed: 30271411google scholar: lookup
  14. Kosmachevskaya OV, Shumaev KB, Topunov AF. Carbonyl Stress in Bacteria: Causes and Consequences.. Biochemistry (Mosc) 2015 Dec;80(13):1655-71.
    doi: 10.1134/S0006297915130039pubmed: 26878572google scholar: lookup
  15. Ewaschuk JB, Zello GA, Naylor JM, Brocks DR. Metabolic acidosis: separation methods and biological relevance of organic acids and lactic acid enantiomers.. J Chromatogr B Analyt Technol Biomed Life Sci 2002 Dec 5;781(1-2):39-56.
    doi: 10.1016/s1570-0232(02)00500-7pubmed: 12450652google scholar: lookup
  16. Mungall BA, Pollitt CC. Thermolysin activates equine lamellar hoof matrix metalloproteinases.. J Comp Pathol 2002 Jan;126(1):9-16.
    doi: 10.1053/jcpa.2001.0515pubmed: 11814317google scholar: lookup
  17. Wang L, Pawlak EA, Johnson PJ, Belknap JK, Alfandari D, Black SJ. Expression and activity of collagenases in the digital laminae of horses with carbohydrate overload-induced acute laminitis.. J Vet Intern Med 2014 Jan-Feb;28(1):215-22.
    doi: 10.1111/jvim.12252pmc: PMC3910380pubmed: 24479657google scholar: lookup
  18. Pass MA, Pollitt S, Pollitt CC. Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis?. Equine Vet J Suppl 1998 Sep;(26):133-8.
  19. Reisinger N, Schaumberger S, Nagl V, Hessenberger S, Schatzmayr G. Milk thistle extract and silymarin inhibit lipopolysaccharide induced lamellar separation of hoof explants in vitro.. Toxins (Basel) 2014 Oct 6;6(10):2962-74.
    doi: 10.3390/toxins6102962pmc: PMC4210879pubmed: 25290524google scholar: lookup
  20. Pollitt CC. Basement membrane pathology: a feature of acute equine laminitis.. Equine Vet J 1996 Jan;28(1):38-46.
  21. Miretti S, Volpe MG, Martignani E, Accornero P, Baratta M. Temporal correlation between differentiation factor expression and microRNAs in Holstein bovine skeletal muscle.. Animal 2017 Feb;11(2):227-235.
    doi: 10.1017/S1751731116001488pubmed: 27406318google scholar: lookup
  22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.. Methods 2001 Dec;25(4):402-8.
    doi: 10.1006/meth.2001.1262pubmed: 11846609google scholar: lookup
  23. French KR, Pollitt CC. Equine laminitis: glucose deprivation and MMP activation induce dermo-epidermal separation in vitro.. Equine Vet J 2004 Apr;36(3):261-6.
    pubmed: 15147135doi: 10.2746/0425164044877170google scholar: lookup
  24. Pass MA, Pollitt S, Pollitt CC. Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis?. Equine Vet J Suppl 1998 Sep;(26):133-8.
  25. Reisinger N, Schaumberger S, Nagl V, Hessenberger S, Schatzmayr G. Concentration Dependent Influence of Lipopolysaccharides on Separation of Hoof Explants and Supernatant Lactic Acid Concentration in an Ex Vivo/In Vitro Laminitis Model.. PLoS One 2015;10(11):e0143754.
  26. Sandow C, Fugler LA, Leise B, Riggs L, Monroe WT, Totaro N, Belknap J, Eades S. Ex vivo effects of insulin on the structural integrity of equine digital lamellae.. Equine Vet J 2019 Jan;51(1):131-135.
    doi: 10.1111/evj.12964pubmed: 29758109google scholar: lookup
  27. Visser MB, Pollitt CC. The timeline of metalloprotease events during oligofructose induced equine laminitis development.. Equine Vet J 2012 Jan;44(1):88-93.
  28. Pollitt CC, Pass MA, Pollitt S. Batimastat (BB-94) inhibits matrix metalloproteinases of equine laminitis.. Equine Vet J Suppl 1998 Sep;(26):119-24.
  29. Kyaw-Tanner MT, Wattle O, van Eps AW, Pollitt CC. Equine laminitis: membrane type matrix metalloproteinase-1 (MMP-14) is involved in acute phase onset.. Equine Vet J 2008 Jul;40(5):482-7.
    doi: 10.2746/042516408X270353pubmed: 18178538google scholar: lookup
  30. Daradka M, Pollitt CC. Epidermal cell proliferation in the equine hoof wall.. Equine Vet J 2004 Apr;36(3):236-41.
    pubmed: 15147131doi: 10.2746/0425164044877198google scholar: lookup
  31. de Laat MA, Kyaw-Tanner MT, Nourian AR, McGowan CM, Sillence MN, Pollitt CC. The developmental and acute phases of insulin-induced laminitis involve minimal metalloproteinase activity.. Vet Immunol Immunopathol 2011 Apr 15;140(3-4):275-81.
    doi: 10.1016/j.vetimm.2011.01.013pubmed: 21333362google scholar: lookup
  32. Johnson PJ, Tyagi SC, Katwa LC, Ganjam VK, Moore LA, Kreeger JM, Messer NT. Activation of extracellular matrix metalloproteinases in equine laminitis.. Vet Rec 1998 Apr 11;142(15):392-6.
    doi: 10.1136/vr.142.15.392pubmed: 9586131google scholar: lookup
  33. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mansel RE. Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.. Int J Mol Med 2006 Apr;17(4):583-90.
    pubmed: 16525713
  34. Fleming T, Cuny J, Nawroth G, Djuric Z, Humpert PM, Zeier M, Bierhaus A, Nawroth PP. Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates?. Diabetologia 2012 Apr;55(4):1151-5.
    doi: 10.1007/s00125-012-2452-1pubmed: 22270223google scholar: lookup
  35. Hidmark A, Fleming T, Vittas S, Mendler M, Deshpande D, Groener JB, Müller BP, Reeh PW, Sauer SK, Pham M, Muckenthaler MU, Bendszus M, Nawroth PP. A new paradigm to understand and treat diabetic neuropathy.. Exp Clin Endocrinol Diabetes 2014 Apr;122(4):201-7.
    doi: 10.1055/s-0034-1367023pubmed: 24623503google scholar: lookup
  36. Tóth F, Frank N, Chameroy KA, Bostont RC. Effects of endotoxaemia and carbohydrate overload on glucose and insulin dynamics and the development of laminitis in horses.. Equine Vet J 2009 Dec;41(9):852-8.
    doi: 10.2746/042516409x479027pubmed: 20383981google scholar: lookup

Citations

This article has been cited 1 times.
  1. Stefaniuk-Szmukier M, Piórkowska K, Ropka-Molik K. Equine Metabolic Syndrome: A Complex Disease Influenced by Multifactorial Genetic Factors.. Genes (Basel) 2023 Jul 27;14(8).
    doi: 10.3390/genes14081544pubmed: 37628596google scholar: lookup